We are live on ! Find out more
NMRA icon

Neumora Therapeutics
NMRA

98 hedge funds and large institutions have $41.1M invested in Neumora Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

165% more call options, than puts

Call options by funds: $143K | Put options by funds: $54K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 28

5.63% less ownership

Funds ownership: 40.27% → 34.64% (-5.6%)

15% less funds holding

Funds holding: 115 → 98 (-17)

37% less capital invested

Capital invested by funds: $65.2M → $41.1M (-$24.1M)

40% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 40

Holders
98
Holders Change
-17
Holders Change %
-14.78%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
24
Increased
28
Reduced
28
Closed
40
Calls
$143K
Puts
$54K
Net Calls
+$89K
Net Calls Change
-$63K

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$798K
2
GCP
GSA Capital Partners
United Kingdom
+$543K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$491K
4
Millennium Management
Millennium Management
New York
+$389K
5
AC
AlphaCore Capital
California
+$256K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.63M
2
UBS Group
UBS Group
Switzerland
-$1.86M
3
State Street
State Street
Massachusetts
-$1.04M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$803K
5
Bank of America
Bank of America
North Carolina
-$604K
Name Holding Trade Value Shares
Change 		Change in
Stake
QC
101
Quadrature Capital
United Kingdom
– -$89.6K -89,200 Closed
AllianceBernstein
102
AllianceBernstein
Tennessee
– -$88K -88,020 Closed
WC
103
Wexford Capital
Florida
– -$77.9K -77,879 Closed
IIM
104
INTECH Investment Management
Florida
– -$73K -73,044 Closed
Deutsche Bank
105
Deutsche Bank
Germany
– -$67K -67,035 Closed
Mirae Asset Global ETFs Holdings
106
Mirae Asset Global ETFs Holdings
Hong Kong
– -$50K -50,007 Closed
BHCM
107
Brevan Howard Capital Management
Jersey
– -$46.3K -46,254 Closed
CF
108
Corebridge Financial
Texas
– -$41.8K -41,753 Closed
VF
109
Virtu Financial
New York
– -$40K -39,676 Closed
AIM
110
Aigen Investment Management
New York
– -$36.4K -36,360 Closed
Manulife (Manufacturers Life Insurance)
111
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$33.7K -33,671 Closed
T. Rowe Price Associates
112
T. Rowe Price Associates
Maryland
– -$33K -32,548 Closed
D.E. Shaw & Co
113
D.E. Shaw & Co
New York
– -$30.7K -30,748 Closed
ACM
114
ADAR1 Capital Management
Texas
– -$26.1K -26,108 Closed
New York State Common Retirement Fund
115
New York State Common Retirement Fund
New York
– -$26K -26,025 Closed
ProShare Advisors
116
ProShare Advisors
Maryland
– -$25.7K -25,738 Closed
VOYA Investment Management
117
VOYA Investment Management
Georgia
– -$24.3K -24,273 Closed
Handelsbanken Fonder
118
Handelsbanken Fonder
Sweden
– -$22K -21,700 Closed
CWM
119
CIBC World Markets
New York
– -$18.9K -18,911 Closed
PFSRSONJ
120
Police & Firemen's Retirement System of New Jersey
New Jersey
– -$18.5K -18,496 Closed
VIA
121
Virtus Investment Advisers
Connecticut
– -$15.5K -15,516 Closed
State Board of Administration of Florida Retirement System
122
State Board of Administration of Florida Retirement System
Florida
– -$12.9K -12,930 Closed
PCA
123
Pallas Capital Advisors
Massachusetts
– -$12.7K -12,675 Closed
LPT
124
Legacy Private Trust
Wisconsin
– -$12K -12,000 Closed
Ameriprise
125
Ameriprise
Minnesota
– -$11.1K -11,107 Closed
2 3 4
5
6

NMRA Hedge Fund Activity: Q2 2025 in Review

98 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Neumora Therapeutics (NMRA) for Q2 2025, worth a combined $41.1M — down 37% from $65.2M a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of NMRA and 24 opened new positions — a net loss of 16 holders — while 28 trimmed existing stakes and 28 added.

The largest buyer was Two Sigma Advisers, adding an estimated $798K. The largest seller was BlackRock, cutting an estimated $2.63M.

  • 98 institutional investors held Neumora Therapeutics (NMRA) as of Q2 2025, down from 115 in Q1 2025.
  • Funds reported $41.1M of Neumora Therapeutics stock for Q2 2025, down 37% quarter-over-quarter.
  • 24 funds opened new Neumora Therapeutics positions in Q2 2025 and 40 closed out, a net change of -16 holders.
  • The largest Neumora Therapeutics buyer in Q2 2025 was Two Sigma Advisers, an estimated $798K added.
  • The largest Neumora Therapeutics seller in Q2 2025 was BlackRock, an estimated $2.63M sold.

Based on aggregated 13F filings for Q2 2025.